Publicaciones en colaboración con investigadores/as de Hannover Medical School (43)

2024

  1. Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants

    npj Genomic Medicine, Vol. 9, Núm. 1

  2. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

    The Lancet Rheumatology, Vol. 6, Núm. 6, pp. e374-e383

2023

  1. High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome

    Journal of Autoimmunity

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

2021

  1. A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome

    Nature Communications, Vol. 12, Núm. 1

  2. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

    Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085

  3. Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases

    Scientific Reports, Vol. 10, Núm. 1

  2. Standardization procedure for flow cytometry data harmonization in prospective multicenter studies

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

2018

  1. A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility

    PLoS ONE, Vol. 13, Núm. 12

2017

  1. A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

    American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74

2016

  1. Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies

    Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344

  2. Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 8, pp. 1521-1526

  3. LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition

    Clinical and Experimental Rheumatology

2015

  1. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35

  2. PXK locus in systemic lupus erythematosus: Fine mapping and functional analysis reveals novel susceptibility gene ABHD6

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 3

2014

  1. A candidate gene approach identifies an IL33 genetic variant as a novel genetic risk factor for GCA

    PLoS ONE, Vol. 9, Núm. 11

  2. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

    Arthritis Research and Therapy, Vol. 16, Núm. 1

  3. Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus

    Arthritis and Rheumatology